Genomate Health CEO Nabil Hafez will participate in JPM Healthcare Week 2026, attending several events during the week. He welcomes meetings with partners and investors to discuss scaling precision oncology through computational reasoning.

JPM Healthcare Week brings together leaders across biotech, pharma, healthcare innovation, and investment. For Genomate Health, it is an important moment to connect with peers and partners who are thinking deeply about how to scale precision oncology in real-world clinical settings.

Nabil is particularly interested in connecting with individuals and organizations who are:

• Exploring clinical decision support and data-driven oncology workflows
• Working on biomarker-driven therapies and patient stratification
• Thinking about how to scale precision medicine beyond academic centers
• Interested in partnerships across biotech, pharma, diagnostics, health systems, or payers

If you will be in San Francisco during JPM Healthcare Week and would like to exchange perspectives, let's meet.

‍Book a meeting here ↘